MedTrace Logo

Aspirin and the Risk of Microscopic Hematuria in Asymptomatic Screened Population

NCT01615315 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60048

Last updated 2012-08-28

No results posted yet for this study

Summary

Aspirin can increase the risk of bleeding tendency. However, correlation between aspirin treatment and hematuria in general population is not well known. The investigators will evaluate whether daily use of aspirin increase the risk of microscopic hematuria in healthy large screened populations.

Conditions

  • Asymptomatic General Population
  • Microscopic Hematuria

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    collaborator OTHER

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

Eligibility

Min Age
20 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2012-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01615315 on ClinicalTrials.gov